Biodexa Pharmaceuticals PLC (BDRX)
4.65
+0.25
(+5.68%)
USD |
NASDAQ |
Nov 22, 11:13
Biodexa Pharmaceuticals Shareholders Equity (Quarterly): 11.04M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.04M |
| June 30, 2024 | 11.04M |
| December 31, 2023 | 5.959M |
| June 30, 2023 | 6.684M |
| June 30, 2023 | 6.684M |
| December 31, 2022 | 3.827M |
| June 30, 2022 | 9.086M |
| June 30, 2022 | 9.086M |
| December 31, 2021 | 14.11M |
| June 30, 2021 | 5.193M |
| June 30, 2021 | 5.193M |
| December 31, 2020 | 9.156M |
| June 30, 2020 | 5.597M |
| June 30, 2020 | 5.597M |
| December 31, 2019 | 25.64M |
| Date | Value |
|---|---|
| June 30, 2019 | 31.37M |
| June 30, 2019 | 31.37M |
| December 31, 2018 | 21.47M |
| June 30, 2018 | 30.56M |
| June 30, 2018 | 30.56M |
| December 31, 2017 | 46.86M |
| June 30, 2017 | 47.90M |
| June 30, 2017 | 47.90M |
| December 31, 2016 | 56.17M |
| June 30, 2016 | 54.83M |
| June 30, 2016 | 54.83M |
| December 31, 2015 | 69.46M |
| June 30, 2015 | 58.38M |
| June 30, 2015 | 58.38M |
| December 31, 2014 | 65.35M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.827M
Minimum
Dec 2022
25.64M
Maximum
Dec 2019
8.926M
Average
6.684M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 79.99M |
| Verona Pharma PLC | 130.49M |
| NuCana PLC | 4.806M |
| Autolus Therapeutics PLC | 476.96M |
| TC BioPharm (Holdings) PLC | 1.364M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.67M |
| Total Liabilities (Quarterly) | 6.628M |